Use of genetically-engineered pig donors in islet transplantation

doi:10.5500/wjt.v5.i4.243

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6949)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

459

WORD

311

HTML

3416

Figures (1-1)

273

Tables (1-2)

217

Sum=4676

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

909

Download

1364

Sum=2273

Dec 24, 2015 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transplant. Dec 24, 2015; 5(4): 243-250
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.243

Table 2 Several genetic manipulations of pigs currently available with potential use for clinical islet transplantation

GE manipulation	Target	Expression	Ref.
GTKO	Humoral response	Ubiquitous	[15,16,46]
NeuGcKO	Humoral response	Ubiquitous
B4GalNT2KO	Humoral response	Ubiquitous
HumanCD46	Complement regulation	Ubiquitous	[12,16]
HumanCD55	Complement regulation	Ubiquitous	[46]
HumanCD59	Complement regulation	Ubiquitous	[46]
HumanTFPI	Anticoagulation	Beta cells	[16]
HumanCD39	Anticoagulation	Beta cells
Human thrombomodulin	Anticoagulation
Human A20 (tumor necrosis factor-alpha-induced protein 3)	Anticoagulation/anti-inflammatory/anti-apoptotic gene expression
Human heme oxygenase-1	Anticoagulation/anti-inflammatory/anti-apoptotic gene expression
Human signal regulatory protein α	Anticoagulation/anti-inflammatory/anti-apoptotic gene expression
CTLA4-Ig (CD152)	Cellular response	Beta cells	[16]
HLA-E/human b2-microglobulin	Cellular response
LEA29Y	Cellular response
PERV siRNA	PERV activation

GE: Genetically-engineered; GTKO: Alpha1,3-galactosyl transferase-gene knockout; TFPI: Tissue factor pathway inhibitor; PERV: Porcine endogenous retroviruse.

Citation: Bottino R, Trucco M. Use of genetically-engineered pig donors in islet transplantation. World J Transplant 2015; 5(4): 243-250
URL: https://www.wjgnet.com/2220-3230/full/v5/i4/243.htm
DOI: https://dx.doi.org/10.5500/wjt.v5.i4.243